News and Press Releases

David Begg Associates Opens New Office in Boston

FOR IMMEDIATE RELEASE

December 17, 2008

CONTACT: Greta Houlahan
Phone: (+1) 734-913-5723
Email: houlahan@nsf.org

 

David Begg Associates Opens New Office in Boston

The NSF International Company's New Location Will Help Meet the Growing U.S. & Canadian Demand for Pharmaceutical Services

BOSTON, Mass. – NSF International owned company, David Begg Associates (DBA), has opened an office in Boston, Massachusetts. The new regional location will be home to DBA’s pharmaceutical consulting, training, and auditing services in North America.

“The move is in response to the growing U.S. and Canadian demand for in-house and residential professional training, as well as auditing and consulting services to help companies within the pharmaceutical and biopharmaceutical industries stay current with new regulatory requirements,” said Lori Bestervelt, Ph.D., NSF Senior Vice President and Chief Technical Officer.

NSF International acquired DBA in September 2007 to expand NSF’s unique pharmaceutical service offerings to the European market. DBA provides unmatched pharmaceutical regulatory and technical knowhow through its highly experienced team of partners and associates in Europe and now in the U.S.

“Last year about 12 percent of our business came from the USA and Canada, and this year that number is expected to be significantly larger,” said Dr. Bob Petrowski, Managing Partner of David Begg Associates. “Opening the new office was the logical next step.”

According to Dr. Bestervelt, “Opening the new location will also facilitate faster, more cost-effective service offerings to our American and Canadian customers.”

To help provide a smooth transition and enhance service offerings at the new U.S. office, DBA has hired Mr. Jim Morris, formerly the Deputy Director of Quality Assurance (QA)/Quality Control (QC) and Regulatory Affairs at MassBiologics. Two additional people with extensive pharmaceutical experience have also recently joined the U.S. team – Ms. Karen Migliaccio and Mr. Glenn Sutker.

DBA’s U.S. team offers a broad range of skills and in-depth experience for pharmaceutical clients seeking both strategic and pragmatic solutions to their quality management, cGMP and regulatory compliance issues, as well as high-quality training for their staff. The U.S. office will be able to call upon the assistance of the DBA UK office to provide specific services, just as the UK office will now be able to offer the unique service offerings of the U.S. team to clients in Europe and beyond.

 

Jim Morris, Partner

Jim Morris, MBA
Partner

Morris has significant experience in plant operations in the U.S. and Europe. He has held positions as Deputy Director of QA/QC and Regulatory Affairs at MassBiologics, Director of QA/QC for the biologics business unit of Cilag AG and a number of QA and manufacturing roles with Pfizer over a 16-year time frame, including heading up QA for Pfizer in Latina, Italy. His areas of expertise include intravenous or intramuscular (parenteral) pharmaceutical production, as well as a broad range of dosage forms, including human, veterinary and consumer products.

 

Karen Migliaccio, Consultant

Karen Migliaccio, MS Analytical Chemistry
Consultant

Migliaccio is an analytical chemist and has over 27 years of experience working in the pharmaceutical industry. She has held technical, supervisory and management positions in both commercial and Research & Development (R&D) quality functions. Most recently, Migliaccio held the position of Senior Director of Quality Operations (QO) at Pfizer’s Groton, Connecticut R&D location. She also has experience in GMP requirements, regulatory inspections and quality systems development and implementation.

 

Glenn Sutker, Consultant

Glenn Sutker, MS Analytical Chemistry
Consultant

Sutker retired from Pfizer, Inc. in 2008 after nearly 35 years of service in Global Manufacturing Quality Operations. At Pfizer, he served in a number of roles with increasing responsibility. Sutker most recently served as Vice President of the QO Center and was responsible for leading the QO site support, Global Manufacturing Compliance and Global Quality Analytical Resources (laboratory) units. He also served as Laboratory Manager, QA Manager, QO Director, Area Leader/Senior Director/Vice President of QO for Europe, Ireland/Singapore and the Americas.

 

“DBA’s U.S. team brings exceptional industry perspective and expertise to our expanding North American client base,” said Kevan P. Lawlor, NSF President and Chief Executive Officer. “I am confident that these outstanding individuals will work closely with DBA’s U.K. office to enhance DBA’s unparalleled services and reputation as a leader in the global pharmaceutical industry.”

NSF has offices and laboratories located worldwide to help clients with international public health and safety regulation issues. For more information, visit NSF’s international Web site.

About David Begg Associates: Established in 1986 to provide expert services to the pharmaceutical and biopharmaceutical industries, David Begg Associates has an outstanding international reputation in the field of pharmaceutical quality management, regulatory compliance and, in particular, for its high-quality training courses (http://www.dba-global.com/).

About NSF International: NSF International, an independent, not-for-profit organization, helps protect you by certifying products and writing standards for food, water and consumer goods (www.nsf.org). Founded in 1944, NSF is committed to protecting public health and safety worldwide. NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment. Additional services include safety audits for the food and water industries, management systems registrations delivered through NSF International Strategic Registrations, organic certification provided by Quality Assurance International and education through the NSF Center for Public Health Education.


Bookmark and Share